Skip to content

Efficacy of EPs 7630 compared to placebo in children with acute non-streptococcal tonsillopharyngitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN27398531
Enrollment
124
Registered
2003-03-26
Start date
2003-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute tonsillopharyngitis Respiratory Tonsillopharyngitis

Interventions

124 Children were randomised to receive either: 1. Herbal remedy EPs 7630, 20 drops three times daily 2. Placebo, 20 drops three times daily. The duration of individual treatment lasted over a maximu

Sponsors

ISO Arzneimittel GmbH & Co KG (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who met the following inclusion criteria were suitable for the trial: 1. Age 6 - 10 years, acute tonsillopharyngitis, duration of complaints less than 48 hours, negative dip-and-react-test test for beta-hemolytic streptococcus and severity of symptoms greater than or equal to 8 points 2. In addition legal guardians had to sign an informed consent

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Ukraine

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026